Biotech Startups

Reaction Biology provides drug discovery and development services for pharmaceutical companies, offering preclinical research platforms including biochemistry, in vivo efficacy testing, and patient-derived xenograft models.

1 investor

ReactWise develops AI tools for chemistry and chemical engineering, enabling researchers and engineers to accelerate molecular discovery and reaction optimization. The company combines machine learning with chemistry automation and high-throughput experimentation platforms.

1 investor

ReadoutAI offers AI tools that automatically analyze clinical trial data, running statistics and generating tables, graphs, and written summaries of the findings. Results are provided as downloadable Word or Excel files for clinical trial researchers.

1 investor

Real Life Sciences develops Natural Language Processing platforms for pharmaceutical and contract research organizations to discover novel insights from clinical and real-world data while protecting patient identity and confidential information.

1 investor

Realbio (锐翌生物) operates a human microbiome medical and gut microbiota health management business, offering a full-cycle service covering early detection, microbiota transplantation, and microbiome-based conditioning. It provides integrated solutions to medical aesthetics and health management institutions in China.

1 investor

Company operating across a medicinal plant value chain, from contract farming and harvesting through to production of essences, extracts, nano-emulsions, and finished consumer products for pharmaceutical, food, and cosmetic industries.

1 investor

RealSeq Biosciences develops RNA fragmentomics technology for advanced diagnostics, enabling detection and analysis of RNA fragments to discover new biomarkers and provide deeper insights into disease. The company serves the healthcare and diagnostics industry by unlocking previously inaccessible biological information from RNA.

1 investor

Reapplix develops advanced wound care products and therapeutics for clinical use. The company serves healthcare systems and wound care providers in the medical device and regenerative medicine sector.

1 investor

Reccan is a medtech company focused on improving early diagnosis and prognosis for patients with pancreatic cancer through the development of biomarker-based diagnostic tools. The company leverages decades of clinical and translational research at Lund University Hospital to address limitations in existing tumor markers.

1 investor

Recognify is a biotech company developing therapeutic and diagnostic products for CNS disease, oncology, and infectious disease. The company is led by experienced drug development and clinical executives with backgrounds across major pharmaceutical and biotech organizations.

1 investor

Adularia (Recolony) develops cancer immunotherapies based on microbiome research, using a microbial metabolite mechanism that activates tumor-residing macrophages to trigger an anti-tumor immune response. The company designs an optimized, tumor-targeted immunotherapy molecule using multi-omics and AI-driven molecule design.</parameter> <parameter name="founders">[{"full_name": "Ana Montalban-Arques", "title": "CEO & Co-Founder"}, {"full_name": "Philipp Busenhart", "title": "COO & Co-Founder"}, {"full_name": "Egl\u0117 Katkevi\u010di\u016bt\u0117", "title": "CSO & Co-Founder"}, {"full_name": "David Seeberger", "title": "CFO"}]

1 investor

Recombinetics develops gene-edited animals, offering custom gene-edited swine models for translational preclinical and biomedical research, including reporter and cancer models. It also applies gene editing to food animals to improve animal health, welfare, and sustainability in agriculture.

1 investor

Reconnect Labs develops precision neuropsychiatry approaches to treat sleep, anxiety, and addiction disorders, drawing on clinical drug development and psychiatric research. It operates in the neuropsychiatry and clinical drug development space.

1 investor

Specialty biopharmaceutical company developing differentiated prescription drugs for analgesia, anesthesia, sedation, and chronic pain management.

1 investor

1 investor

RedDress develops autologous wound healing solutions, including its ActiGraft/ActiGraftPro product that uses a patient's own blood to create a blood-derived clot for treating chronic, non-healing wounds. It sells to healthcare providers and clinicians, with products eligible for Medicare reimbursement in the U.S.

1 investor

RedShiftBio develops analytical technology that provides real-time measurement of biomolecular structure and concentration, aimed at supporting decisions in biopharmaceutical development and manufacturing.

1 investor

Red Tree is a life science venture capital firm using a West Coast-focused, early-stage investment strategy. It backs entrepreneurs developing first-in-class or best-in-class therapeutics in oncology, neurology, and immunology.

1 investor

Reduced Foods uses a proprietary fermentation and koji-based "Waste-2-Taste" technology to upcycle food side streams into flavour ingredients that deliver umami, kokumi, and maillard notes as clean-label alternatives to MSG, yeast extracts, and hydrolyzed vegetable proteins. The company serves industrial food producers and positions its ingredients as lower-carbon, sustainable options.

1 investor

Redux Bio develops bio-based vaccines and biological solutions for animal health and aquaculture, including fish and other livestock products. The company focuses on early discovery, development, and scale-up of vaccines and industrial biotech products for the animal health industry.

1 investor

Developed site-specific protein conjugation and linker technologies; acquired by Catalent Pharma Solutions in 2014.

1 investor

Redx is a clinical-stage biotechnology company developing small molecule targeted medicines focused on fibrotic diseases, leveraging ROCK pathway inhibitors and novel targets. The company also maintains an oncology pipeline with partnered and in-house programs for unmet medical needs.

1 investor

Rees Scientific manufactures centralized monitoring systems for facilities, including hardware platforms and cloud-based solutions for tracking critical equipment and environmental conditions. The company serves industrial and facility management operations requiring compliance, scalability, and remote monitoring capabilities.

1 investor

Reference Medicine supplies biological specimens to researchers and diagnostics developers working on cancer diagnostic tools. The company sources materials to support biotech and life sciences research.

1 investor